Director médico e Investigador PrincipalMarian Testeo
mariano puglia
Paula Accialini
sponsorPenTest3 SponsorPenTest
DIRECTORpenTest1 Demo Pen Test 1
Open studies
Chronic bronchitis
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR) - PILLAR - Chiesi Farmaceutici S.p.A.See more
Chronic obstructive pulmonary disease
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR) - PILLAR - Chiesi Farmaceutici S.p.A.See more
Flu
Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment - RESFRIN - Eurofarma Laboratorios S.A.See more
Skin cancer
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer - GlaxoSmithKlineSee more